The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease.
about
Role of Cannabinoids in Gastrointestinal Mucosal Defense and InflammationProteomic analysis of colonic mucosal tissue from tuberculous and ulcerative colitis patients.Altered expression of type-1 and type-2 cannabinoid receptors in celiac diseaseMultitarget fatty acid amide hydrolase/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti-inflammatory drug-dependent gastrointestinal damage.RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectivesPotent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies.A Double Whammy: Targeting Both Fatty Acid Amide Hydrolase (FAAH) and Cyclooxygenase (COX) To Treat Pain and Inflammation.Metabolism of Anandamide by Human Cytochrome P450 2J2 in the Reconstituted System and Human Intestinal Microsomes.Protective Action of Anandamide and Its COX-2 Metabolite against l-Homocysteine-Induced NLRP3 Inflammasome Activation and Injury in Podocytes.Therapeutic Use of Cannabis in Inflammatory Bowel Disease.IBD: Patients with IBD find symptom relief in the Cannabis field.Characterization of endocannabinoid-mediated induction of myeloid-derived suppressor cells involving mast cells and MCP-1.Downstream effects of endocannabinoid on blood cells: implications for health and disease.Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK.The Role of the Endocannabinoid System in the Brain-Gut Axis.Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?Endocannabinoids in the gastrointestinal tract.Cross sectional evaluation of the gut-microbiome metabolome axis in an Italian cohort of IBD patients.Cannabis finds its way into treatment of Crohn's disease.Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH).
P2860
Q30357558-0A43F78E-A7F9-4CE2-9FA1-F0EF1C240FC9Q34339382-923A0C1D-43D1-4452-88AB-67A95515928AQ34689405-34B03F2C-D845-42F1-87E4-5E10F45E634DQ35660108-A72E827D-896B-4EB1-BD53-247737ABA913Q35906057-2C9D0C29-CEBD-4463-A3F8-B46680CD93A6Q36576347-07160FFF-54B4-4C12-8A4D-A5ED0A5260BFQ36823364-224E5A50-5317-4A57-ABD1-4A7409227702Q36947747-614DB7BD-91A8-40C9-8F43-F58AB2440593Q37062591-87A2FFF6-0572-4276-9FA2-B965A8DB595CQ37540208-F5DC3F8A-ED1E-42F3-B925-CFFCF95539C6Q37627086-AAF3147F-42CB-4635-8BAB-787B2A4E2DE6Q37644978-D1E8210F-B36A-419F-B341-04D7323A8492Q38468985-73642506-9CE0-4C74-BE68-2C06F8CAFD0DQ38786805-07DF906C-E715-4EC8-927E-535AAA89446DQ38822341-77277E4D-3CF9-4B88-893C-B2FBB1FEB0F8Q38918638-0C6D8B86-3452-434A-982E-DC5F42043486Q38931168-FC293BD7-507A-4557-8F7E-2DCDC75691CCQ41534067-A8427D4E-D4A3-43E5-B7E1-AF118753FB04Q41542729-1FDEB3C4-5228-4303-B5B6-F6B3232748B1Q42012570-8B98592B-AC32-4C2B-8C51-1E61F633057C
P2860
The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease.
@en
The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease.
@nl
type
label
The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease.
@en
The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease.
@nl
prefLabel
The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease.
@en
The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease.
@nl
P2093
P50
P921
P356
P1433
P1476
The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease
@en
P2093
D Piomelli
L Rovedatti
M Maccarrone
P Biancheri
S L F Pender
T T MacDonald
P2888
P304
P356
10.1038/MI.2011.18
P577
2011-04-06T00:00:00Z